๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
This Phase I, open-label, dose-finding, multicenter study is designed to de...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-11-13
Trial ID
NCT02215096
Treatments Being Tested
The study consists of a pre-screening period to determine if the subject's ...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-11-10
Trial ID
NCT01458067
Treatments Being Tested
The goal of this clinical research study is to learn if GSK2636771 given in...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2017-07-17
Trial ID
NCT03131908
Treatments Being Tested
This phase II MATCH screening and multi-sub-trial studies how well treatmen...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2015-08-17
Trial ID
NCT02465060
Treatments Being Tested
This phase II MATCH treatment trial identifies the effects of GSK2636771 in...
Status
Active Not Recruiting
Location
ECOG-ACRIN Cancer Research Group
Start Date
2016-03-21
Trial ID
NCT04439188
Treatments Being Tested
This is a Phase Ib/IIa, open-label, non-randomized, dose-escalation, multi-...
Status
Completed
Location
Severance Hospital, Yonsei University Health System, Yonsei Cancer Center
Start Date
2016-02
Trial ID
NCT02615730
Treatments Being Tested
This phase II MATCH treatment trial identifies the effects of GSK2636771 in...
Status
Active Not Recruiting
Location
ECOG-ACRIN Cancer Research Group
Start Date
2016-05-05
Trial ID
NCT04439149
Treatments Being Tested
In-depth understanding of molecular characteristics of gastric cancer enabl...
Status
Completed
Location
Severance Hospital, Yonsei University Health System, Yonsei Cancer Center
Start Date
2016-01-01
Trial ID
NCT02951091
Treatments Being Tested